JP Morgan Cazenove today reaffirms its overweight investment rating on London Stock Exchange Group PLC (LON:LSE) and raised its price target to 7900p (from 7700p)....
Faron Pharmaceuticals said it planned to recruit extra patients into its cancer trial after a data monitoring committee confirmed the safe dose range of the...
RBC Capital Markets today reaffirms its underperform investment rating on Smiths Group PLC (LON:SMIN) and raised its price target to 1550p (from 1500p).